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Epoxide hydrolases catalyze the cofactor-independ-
ent hydrolysis of reactive and toxic epoxides. They play
an essential role in the detoxification of various xenobi-
otics in higher organisms and in the bacterial degrada-
tion of several environmental pollutants. The first x-ray
structure of one of these, from Agrobacterium ra-
diobacter AD1, has been determined by isomorphous
replacement at 2.1-Å resolution. The enzyme shows a
two-domain structure with the core having the a/b hy-
drolase-fold topology. The catalytic residues, Asp107 and
His275, are located in a predominantly hydrophobic en-
vironment between the two domains. A tunnel connects
the back of the active-site cavity with the surface of the
enzyme and provides access to the active site for the
catalytic water molecule, which in the crystal structure,
has been found at hydrogen bond distance to His275.
Because of a crystallographic contact, the active site has
become accessible for the Gln134 side chain, which occu-
pies a position mimicking a bound substrate. The struc-
ture suggests Tyr152/Tyr215 as the residues involved in
substrate binding, stabilization of the transition state,
and possibly protonation of the epoxide oxygen.
Epoxide hydrolases (EC 3.3.2.3) are a group of functionally
related enzymes that catalyze the cofactor-independent hydrol-
ysis of epoxides to their corresponding diols by the addition of
a water molecule. Epoxides are very reactive electrophilic com-
pounds frequently found as intermediates in the catabolic path-
way of various xenobiotics. For instance they are the carcino-
gens formed by bioactivation reactions catalyzed by cytochrome
P450. Therefore, conversion of epoxides to less toxic, water-
soluble compounds is an essential detoxification step in living
cells. Consequently, epoxide hydrolases have been found in a
wide variety of organisms, including mammals, invertebrates,
plants, and bacteria (1).
Until now most research has been focused on mammalian
epoxide hydrolases (2, 3), which, together with glutathione
S-transferases, are the most important enzymes to convert
toxic epoxides to more polar and easily excretable compounds
(4). However, much progress has recently also been made in the
characterization of bacterial epoxide hydrolases (5, 6, 7). These
enzymes show a significant sequence homology with those of
mammalian origin. They can be easily obtained in large
amounts, and they exhibit enantioselectivity with various in-
dustrially important epoxides, which makes them promising
biocatalysts for the large scale preparation of enantiopure ep-
oxides and/or their corresponding vicinal diols (8). In particu-
lar, extensive studies have been performed on the epoxide
hydrolase from Agrobacterium radiobacter AD1, a Gram-nega-
tive bacterium that is able to use the environmental pollutant
epichlorohydrin as its sole carbon and energy source (5, 6, 8).
This epoxide hydrolase is a soluble monomeric globular protein
of 35 kDa with a broad substrate range. Epichlorohydrin and
epibromohydrin are its best substrates, and the optimum pH
range for catalysis is 8.4–9.0. Sequence and secondary struc-
ture analysis suggested that this enzyme belongs to the a/b
hydrolase-fold family of enzymes (9). Site-specific mutations
indicated Asp107, His275, and Asp246 as the catalytic triad res-
idues. The proposed catalytic mechanism involves two steps
analogous to haloalkane dehalogenase (10). In the first reaction
step, an ester bond is formed between enzyme and substrate by
attack of the nucleophilic Asp107 on the primary carbon atom of
the substrate; in the second step, this ester bond is hydrolyzed
by a water molecule activated by the His275/Asp246 pair. The
reaction proceeds via two different transition states, one during
the binding and opening of the epoxide ring and the second
during the hydrolysis of the ester intermediate. However, sev-
eral important questions remained unanswered. Until now it
has not been possible to identify the residue responsible for the
binding and protonation of the epoxide oxygen, nor was the
location known of the oxyanion hole that stabilizes the Asp107
oxyanion during the hydrolysis of the ester intermediate.
Structural information may also resolve why an Asp246 3 Ala
mutant still retains some residual activity (6).
Here we report the 2.1-Å resolution x-ray structure of the
epoxide hydrolase from A. radiobacter AD1 (Ephy).1 It is the
first epoxide hydrolase for which the structure has been solved.
The result of this work can provide a general better under-
standing about the structural basis of the reaction mechanism
for this class of important ubiquitous enzymes.
EXPERIMENTAL PROCEDURES
Crystallization and Heavy Atom Search—The epoxide hydrolase
from A. radiobacter AD1 was cloned, overexpressed, and purified as
described previously (6). The stock protein solution, containing 5 mM
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potassium phosphate, 1 mM EDTA, 1 mM b-mercaptoethanol, 0.02%
sodium azide, and 10% glycerol (pH 6.8) was concentrated and exten-
sively washed using 10 mM potassium phosphate (pH 7.0) in a Centri-
con-10 ultracentrifugation concentrator with a 10-kDa cut-off (Amicon)
to a final protein concentration of 5.5 mg/ml. The extensive washing
procedure is essential to remove the glycerol before crystallization. The
glycerol induces high polydispersity in the protein sample, as was
determined by dynamic light scattering analysis on a DynaPro 801
instrument (Protein Solutions, Charlottesville, VA). Removing the glyc-
erol resulted in a solution containing particles with a 2.7-nm diameter
(apparent molecular mass of 33 kDa) and a polydispersity of 15%.
Crystallization experiments with the protein in the presence of glycerol
gave only very thin needles as a best result. An initial promising
crystallization condition was obtained from a Sparse Matrix screening
(11). Refinement of this Sparse Matrix condition resulted in the follow-
ing crystallization protocol: hanging drops (4 ml of protein solution and
4 ml of precipitant) were equilibrated against a 1-ml reservoir contain-
ing 1.6 to 1.8 M KH2PO4/K2HPO4 (pH 7.0) at room temperature. After 2
weeks, the experiments were allowed to slowly evaporate to a phos-
phate concentration of about 2.0 M. The slow increase of the phosphate
concentration in the drop results in the appearance of crystals with
typical sizes of 0.3 3 0.2 3 0.1 mm3. They are highly x-ray-sensitive,
and therefore, all data collections were performed at cryotemperature
(100 K), using 30% glycerol added to the stabilizing mother liquor (1.8
M KH2PO4/K2HPO4) as a cryoprotectant.
The crystals diffract up to 2.1-Å resolution using synchrotron ra-
diation, and they belong to space group C2 with unit cell parameters
of a 5 146.62 Å, b 5 100.20 Å, c 5 96.88 Å, b 5 100.68°. This unit cell
gives a VM value of 2.57 Å
3/Da21 assuming 4 molecules in the asym-
metric unit. The deduced solvent content of the crystals is 52%.
Heavy atom derivatives were prepared by soaking the crystals in
solutions obtained by dissolving the heavy atom compounds in the
standard mother liquor (1.8 M KH2PO4/K2HPO4). The search resulted
in only one good isomorphous derivative obtained by soaking a crystal
of epoxide hydrolase for 2 days in a solution of 2.0 mM ethyl mercury
phosphate, (C2H5HgO)3PO.
Data Collection and Processing—A 2.1-Å resolution native data set
and one of the two ethyl mercury phosphate derivative data sets were
collected at the x-ray diffraction beamline of the ELETTRA synchrotron
in Trieste (Italy), equipped with a 30-cm MAR image plate area detector
(MAR Research, Hamburg, Germany) with the wavelength tuned to l 5
1.0 Å. An in-house derivative data set was collected on a Mac Science
DIP-2030H area detector equipped with a dual 30-cm image plate, with
graphite monochromatized CuKa radiation (l 5 1.5418 Å) from a
FR591 rotating anode generator with a double mirror x-ray focusing
system (model MAC-XOS) as x-ray source (Enraf Nonius, Delft, The
Netherlands). All data sets were collected at 100 K, integrated, and
merged using the DENZO/SCALEPACK package (12) and software
from the BIOMOL crystallographic package (Protein Crystallography
Group, University of Groningen). Derivative data were scaled to the
native data set using the program PHASES (13). Data-processing sta-
tistics are given in Table I.
Structure Determination and Refinement—The structure of the ep-
oxide hydrolase from A. radiobacter AD1 was solved by the method of
single isomorphous replacement supplemented by anomalous scatter-
ing, using both the in-house and synchrotron derivative data sets. A
major heavy atom site (8.5 s) for the ethyl mercury phosphate deriva-
tive was located in a difference Patterson map (12.0–4.5-Å data). The
remaining 21 heavy atom positions were determined using difference
Fourier techniques. Heavy atom position search, parameter refinement
including anomalous data, and phase calculations were performed with
PHASES (13) (Table I). The initial phases calculated at 3.7 Å yielded a
figure of merit of 0.47 and were improved by solvent flattening and
histogram matching techniques using the program DM (14). The non-
crystallographic symmetry (NCS) operators (three orthogonal 2-fold
axes) relating the 4 molecules in the asymmetric unit were determined
with the help of FINDNCS,2 using the 8 heavy atom sites with the
highest occupancies. They were checked by comparing them with the
rotation matrices calculated from a self-rotation function (16). An initial
mask was built around one molecule in the asymmetric unit with the
program MAMA (17); this mask was then used to refine the NCS
operators by maximizing the correlation between the electron density
maps of the 4 molecules in the asymmetric unit using the program IMP
(17). Iterative cycles of density averaging, improvement of the mask,
and refinement of the NCS operators, along with solvent flattening and
phase extension to 2.6 Å resolution, resulted in a map of interpretable
quality.
The model was traced using the program O (18). Nearly the complete
polypeptide chain of one monomer could be interpreted in agreement
with the amino acid sequence. By applying the refined NCS operators to
the coordinates of the first molecule, coordinates for the other three
molecules in the asymmetric unit were generated. The four molecules
were then refined using the program X-PLOR (19). During the first runs
of the refinement (simulated annealing and individual B-factor refine-
ment), tight NCS restraints were applied (17), but in the final stage of
the refinement (conventional positional refinement and individual B-
factor refinement), they were gradually released or not even used at all
for those residues that clearly showed different conformations in the 4
monomers in the asymmetric unit. The best refinement results were
obtained using a flat bulk solvent correction. Special care was taken in
the selection of the test set for the Rfree calculation; the test set was
selected by dividing the reflections in 102 thin-resolution shells to
minimize the correlation between test set and working set reflections
that could be caused by the presence of NCS (20). Water molecules were
placed according to strict density and distance criteria, starting with
the buried and NCS-related ones.
The final model consists of 4 3 282 residues, 610 water molecules
(33 of them refined with double positions), and 4 potassium ions. The
crystallographic R factor and Rfree are 19.0% and 22.7%, respectively.
PROCHECK (21) and WHATCHECK (22) were used to assess the
stereochemical quality. The structure was further analyzed using the
2 G. Lu, http://gamma.mbb.ki.se/;guoguang/findncs.html.
TABLE I
Data collection and single isomorphous replacement including anomalous scattering (SIRAS) analysis
Data set Native (l 5 1.0 Å) Hga (l 5 1.0 Å) Hga (l 5 1.5418 Å)
Space group C2 C2 C2
a 5 146.62 Å 147.15 Å 147.05 Å
b 5 100.20 Å 100.14 Å 100.33 Å
c 5 96.88 Å 97.70 Å 97.32 Å
b 5 100.68° 100.94° 100.51°
Resolution 2.1 Å 3.5 Å 4.0 Å
Observations 222,880 65,941 59,453
Unique reflections 73,445 15,782 10,514
Completeness (%) overall (final shell) 91.5 (82.0) 93.9 (91.7) 88.3 (91.2)
Rmerge (final shell)
b 0.06 (0.36) 0.13 (0.23) 0.12 (0.25)
Phasing
Heavy atom sites 22 22
Phasing power (iso/ano)c 1.80/1.87 2.01
Figure of merit (iso/ano)d 0.35/0.40 0.42
Figure of merit overall 0.47
RCullis
e 0.49 0.43
a The Hg derivative is ethyl mercury phosphate (C2H5HgO)3PO.
b Rmerge 5 (h(iuIhi 2 ^Ih&u/(h(iIhi.
c Phasing power is r.m.s. (uFHu/E), where uFHu is the heavy atom structure factor amplitude, and E is the radial lack of closure (uFPH 2 FPu 2 uFHu).
iso, isomorphous difference; ano, anomalous difference.
d Figure of merit for a given reflection h is m 5 uFbestu/uFhu.
e RCullis 5 (hiFPHu6uFpu 2 FH(calc)u/(huFPH 6 FPi.
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program VOIDOO (23), the programs from the CCP4 suite (14), the
BIOMOL package, and the program DALI (24). Refinement statistics
are given in Table II. The atomic coordinates and the structure
factors have been deposited to the Protein Data Bank with the entry
code 1ehy.
Modeling of Asp246—As a starting model, the atomic coordinates of
the refined structure of the wild type epoxide hydrolase were used in
which only the internal solvent molecules were retained. The crystal
structure was energy-minimized prior to the modeling using a conju-
gate gradient routine implemented in X-PLOR (19). To completely
remove the possible bias because of the conformation of the protein in
the crystal, a slow-cooling molecular dynamics simulation (19) of 25 ps
with temperature coupling (25) was performed in which the tempera-
ture was slowly reduced from 1000 K to 300 K. The missing loop
138–148 and the loop containing Asp246 were built using the program O
(18).
To model a likely conformation of the active Ephy enzyme, we
assumed that the acid member of the catalytic triad, Asp246, should
lie at interaction distance to the catalytic His275 side chain, as found
in many other members of the a/b hydrolase-fold family (9). Haloal-
kane dehalogenase (PDB accession code 2HAD) (26) and bromoper-
oxidase A2 (PDB accession code 1BRO) (27) were used as templates to
model the new Ephy Asp246 position, analogous to Asp260 of dehalo-
genase and Asp228 of bromoperoxidase, respectively. Secondly, we
assumed that the Gln134 side chain should be removed from the active
site, as it blocks the putative substrate binding site. This was done by
giving the Pro132-Ile133-Gln134 loop a similar conformation as the
human pancreatic lipase (PDB accession code 1LPB) (28) Pro177-
Ala178-Glu179 motif, which has an equivalent topological position. The
loop of residues 138–148, which is not observed in the electron
density, was built like in the bromoperoxidase structure, connecting
the core and the cap domains.
Several cycles of stereochemical regularization were performed using
the REFI and LEGO option of O (18). The model was subsequently
subjected to energy minimization to tidy up unacceptable close contacts
and poor stereochemistry. To overcome the possibility that the energy-
minimized structure was trapped in a local minimum, a second molec-
ular dynamics-simulated annealing run was performed using the same
setting as before. Extensive energy minimization was applied until
convergence was reached, leading to a model with no residues outside
the allowed regions in the Ramachandran plot (29) and good stereo-
chemical quality (r.m.s. deviation bond lengths 5 0.005 Å, r.m.s. devi-
ation bond angles 5 1.61°). Asp107 and Asp131 have slightly deviating
backbone torsion angles, like in the x-ray structure.
Although the position of the modeled loop 132–148 is only one of the
possible conformations it can assume, we are confident that the rebuild-
ing of the loop containing Asp246, in a fashion common to many a/b
hydrolase-fold enzymes, gives a plausible picture of the catalytic site of
the fully active epoxide hydrolase.
RESULTS
Quality of the Model—Epoxide hydrolase from A. radiobacter
AD1 (Ephy) crystallizes in the monoclinic space group C2, with
4 molecules in the asymmetric unit. A superimposition of the
Ca atoms of the four molecules gave an average r.m.s. differ-
ence of 0.24 Å for molecules B, C, and D and a higher r.m.s.
difference of 0.40 Å if molecule A is included. All results dis-
cussed below apply to all 4 molecules (A, B, C, and D) unless
stated otherwise. The final model consists of 4 3 282 residues,
610 water molecules (33 of them refined with double positions),
and 4 potassium ions, originating from the crystallization
buffer, one for each molecule in the asymmetric unit. In each
monomer (294 residues), the first N-terminal residue (Met) is
not visible nor is there interpretable electron density for the
loop 138–148. The final crystallographic R factor and Rfree
values are 19.0% and 22.7%, respectively. The r.m.s. deviations
from ideal geometry are 0.008 Å for bond lengths and 1.338° for
bond angles. No residues are in the disallowed regions of the
Ramachandran plot (29). Pro39 was found in a cis conformation.
Overall Structure—The Ephy monomer has a nearly globular
shape with approximate dimensions of 48 3 47 3 47 Å3. It
consists of two domains: domain I (or “core” domain), which
shows the typical features of the a/b hydrolase-fold topology
(9), and the mainly a-helical domain II (or “cap” domain), which
lies on top of domain I (Figs. 1 and 2). The core domain com-
prises amino acids 1–137 and 219–294, and it consists of a
central eight-stranded b-sheet with seven parallel strands
(only the second strand is antiparallel). The b-sheet is flanked
on both sides by a-helices, two on one side and four on the
other. Helix a9 is a one-turn 310 helix. Domain II, containing
a-helices a4 to a8, forms a large excursion between b-strands
b6 and b7 of the core domain. It has a double-layered structure
with helices a7 and a8 located between the core domain and the
plane formed by a4, a5, and a6.
Active Site—The proposed active-site residues (6) Asp107 and
His275 are located in a predominantly hydrophobic internal
cavity between domains I and II. The core domain contributes
to the lining of the cavity with residues Gly37, Trp38, Pro39,
TABLE II
Refinement statistics and stereochemical quality of the final model
Resolution range (Å) 25–2.1
R factora (Rfree
b) 0.190 (0.227)
No. of residues in the asymetric unit 4 3 282
No. of water molecules 610







r.m.s. deviation from ideality
bond lengths (Å) 0.008
bond angles (°) 1.338
Ramachandran plot
Residues in most favored regions (%) 89.7
Residues in additional allowed regions (%) 9.3
Residues in generously allowed regions (%) 1.0
a R factor 5 (hiFobsu 2 uFcalci/(uFobsu, where Fobs and Fcalc are the
observed and calculated structure factor amplitudes, respectively.
b Free R-factor is calculated with 5% of the diffraction data selected
randomly in 102 thin resolution shells that were not used during the
refinement.
FIG. 1. Schematic view of the secondary structure elements
(from DSSP (38)) of the epoxide hydrolase monomer. Ribbon
representation drawn using MOLSCRIPT (39) is shown; a-helices,
b-strands, and coils are represented by helical ribbons, arrows, and
ropes, respectively. The a-helices of the cap domain are shown in dark
gray.
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Glu44, His106, Asp107, Phe108, Ile133, Phe137, Ile219, His275,
Phe276, Val279. The cap domain supplies Tyr152, Trp183, and
Tyr215 (Fig. 3).
Asp107 is situated at the very sharp “nucleophile elbow”
between the central strand b5 and helix a3. At this topological
position, all a/b hydrolase-fold enzymes present the nucleo-
phile, which can either be Ser, Cys, or Asp (9). The (f, c) angles
of Asp107 are slightly unfavorable (f 5 57°, c 5 2124°), but its
conformation is stabilized by a network of hydrogen bonds
involving residues of the sharp turn, as has been found in other
a/b hydrolase enzymes (9). In addition, the main chain nitrogen
atom of Asp107 interacts via a hydrogen bond with the backbone
oxygen atom of Asp131, the other residue with slightly deviating
backbone torsion angles (f 5 31°, c 5 69°). Furthermore, the
side chain of Asp107 is stabilized by a hydrogen bond of its Od2
atom with the backbone amide groups of Trp38 and Phe108 and
by a salt bridge between the Od1 atom of Asp107 and the Ne2
atom of the His275 side chain.
An ;20-Å long tunnel, filled with water molecules, is located
between a-helices a1, a10, the loop connecting a-helix a1 and
b-strand b3 of the core domain, and a7 of the cap domain (Fig.
4). This tunnel leads to the back of the active-site cavity, and it
is perfectly suited to replenish the hydrolytic water molecule at
hydrogen bond distance to the Ne2 atom of the His275 side
chain (Fig. 3) after the reaction. In our structure, the active site
cavity is exposed to the solvent from the front part too, where
the missing loop is located. Because of the position of the
hydrolytic water molecule in the back of the active site, it is
likely that the substrate enters the active-site cavity from the
front part.
Asp246 has been proposed to be the acidic member of the
catalytic triad, responsible for assisting His275 in activating the
water molecule that hydrolyzes the ester intermediate formed
at Asp107 (6). Asp246 is located in a turn between strand b7 and
helix a10, in a position topologically conserved within the a/b
hydrolase-fold family (Fig. 2) (9). However, in our crystal struc-
ture Asp246 is not at interacting distance from His275. Instead
the loop containing this residue is pulled away from the active
site, and the Asp246 side chain is pointing into the solvent. This
is probably the result of crystal packing forces because helix
a10 of molecule A, which follows the loop containing Asp246, is
involved in an intermolecular contact with helix a10 of mole-
cule B. A similar contact exists between molecules C and D,
which even involves an intermolecular disulfide bridge be-
tween Cys(C)248 and Cys(D)248. The absence of this disulfide
bond between molecules A and B results in a slightly different
conformation of the loop containing Cys248 in molecule A com-
pared with the other three molecules in the asymmetric unit.
As a consequence, the difference between the Ca positions of
molecules A, B, C, and D (average r.m.s. difference of 0.40 Å) is
higher than for the B, C, and D molecules only (r.m.s. difference
of 0.24 Å). The conformational plasticity of the region between
residues 244 and 257 is also reflected by very high B-factors
(between 28 Å2 and 84 Å2) and a not easily interpretable
electron density map, often poorly defined or showing multiple
conformations even for the backbone. The space vacated by
Asp246 makes it possible for the side chain of Gln134 to move
into the active site, occupying the site where the substrate is
likely to be bound (Fig. 3). Its position is stabilized by a hydro-
gen bonding network involving the hydroxyl groups of Tyr152
and Tyr215 and the carboxyl oxygen Od1 of Asp107.
Comparison with a/b Hydrolases—The folding of Ephy
strongly resembles that of bromoperoxidase A2 from Strepto-
myces aureofaciens (27) (BpA2, PDB accession code 1BRO;
r.m.s. deviation ;1.7 Å for 193 Ca atoms) and haloalkane
dehalogenase from Xanthobacter autotrophicus (10, 26, 30)
(DhlA, PDB accession code 2HAD; r.m.s. deviation ; 2.0 Å for
204 Ca atoms) and a number of other members of the a/b
hydrolase-fold family (9). The matching is best for the central
b-sheet and for helices a2 and a3 (Fig. 5), but all other struc-
tural elements are equivalent as well, especially in the regions
close to the catalytic residues. The a-helices in the cap domain
superimpose less well, showing a different relative orientation.
These helices contribute several residues important for the
interaction with substrates.
Despite a low sequence homology (33% homology, 20% iden-
tity), the structural similarity of epoxide hydrolase and haloal-
kane dehalogenase is particularly interesting. These enzymes
have both an Asp-His-Asp catalytic triad. Asp107 and His275 of
Ephy superimpose very well on Asp124 and His289 of DhlA;
their side chains are in the same relative position and make
similar hydrogen bonds. In dehalogenase the halogen atom of
the substrate is bound between the indole ring N-atoms of
Trp125 and Trp175. In epoxide hydrolase, Phe108 and Trp183
occupy the equivalent positions, suggesting that they may be
involved in substrate binding (6). However, a stabilizing struc-
tural role for Phe108 is also conceivable, as it has a “T-shaped”
interaction with the Tyr215 side chain (31). In dehalogenase,
FIG. 2. Secondary structure topology diagram and location of the catalytic triad residues, Asp107, Asp246, and His275. The dashed line
represents the missing loop 138–148. Short 310 helices are located at the N terminus (a9), between b3 and a1 (a91), between b4 and a2 (a92), and
between a3 and b6 (a93). The last a-helix shows a conspicuous bend at residue 281 (a911-a11) because of the presence of Pro282 in the center of the
helix.
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the Od2 atom of Asp124, which in the putative transition state
will become negatively charged, is stabilized by interaction
with the main chain nitrogen atoms of residues 125 and 56.
Asp107 Od2 in Ephy has similar interactions with the amide
nitrogen atoms of residues 108 and 38, suggesting Phe108 and
Trp38 as part of the oxyanion hole.
Modeling of Asp246—As mentioned above, the third catalytic
residue, Asp246, is pulled out of the active site. However, the
positions of Asp260 in haloalkane dehalogenase and Asp228 in
bromoperoxidase A2 give a reliable suggestion where Asp246
should be located in the active conformation of Ephy. Superpo-
sition of the b-sheets of DhlA and BpA2 on that of Ephy brings
the Od2 atom of Asp260 of dehalogenase and Asp228 of bro-
moperoxidase in coincidence with the water molecule in Ephy,
which is hydrogen-bonded to Nd1 of His275 and Od2 of Asp131
(Fig. 6). This information was used to model a likely conforma-
tion of the “active” Ephy enzyme, with DhlA, BpA2, and human
pancreatic lipase (Hpl) structures as templates for reconstruct-
ing the Ephy loops containing Asp246 and Gln134 (See “Exper-
imental Procedures”).
The final model shows an intact and empty active site
cavity, capable of accommodating substrates. It is lined with
Gly37, Trp38, Pro39, Glu44, His106, Asp107, Phe108, Ile133,
Phe137, Tyr152, Trp183, Tyr215, Ile219, Cys248, His275, Phe276,
and Val279 (Fig. 7). Asp246 is hydrogen-bonded to the His275
Nd1, and it now occupies the position where the acidic mem-
ber of the catalytic triad is normally found in a/b hydrolase-
fold enzymes. The rest of the active site has undergone only
minor changes in the relative positions of the atoms. The
hydrolytic water molecule is still present at hydrogen bond
distance to the His275 Ne2 atom. The Tyr152 and Tyr215 hy-
droxyl groups, which in the crystal structure were hydrogen-
bonded to the Gln134 side chain, still point in the same
direction, enabling them to donate the proton needed for
opening of the epoxide ring (Fig. 8).
DISCUSSION
Active Site and Substrate Binding—Epoxide hydrolase has a
two-domain structure (Fig. 1). The core domain displays an a/b
hydrolase-fold topology, which provides the scaffolding for the
catalytic triad residues Asp107, His275, and Asp246, whereas the
a-helical cap domain contributes several residues important for
the interaction with substrates. The active site is located in a
cavity between the two domains, which contains Asp107 and
His275. Asp107 is the nucleophile that attacks the substrate
carbon atom in the first step of the reaction, whereas His275
activates the water molecule that hydrolyzes the ester inter-
mediate in the second reaction step (6). Indeed, in the crystal
structure, a water molecule is visible at hydrogen bond dis-
tance to the Ne2 atom of the His275 side chain. Because of the
crystallization pH (7.0), in the x-ray structure, His275 is stabi-
lized by a salt bridge with Asp107 Od1. At the optimum pH for
catalysis (8.4–9.0) His275 Ne2 is most likely deprotonated and
therefore able to activate the water molecule located nearby. In
FIG. 3. Stereo view of residues lin-
ing the active site of epoxide hydro-
lase. Residues and water molecules are
drawn in ball and stick representation
using MOLSCRIPT (39). The catalytic
water molecule is labeled WAT.
FIG. 4. Stereo view of the tunnel
connecting the back of the active site
with the protein surface. The tunnel
was calculated with VOIDOO (23) using a
probe with radius 1.2 Å. The core and the
cap domain are shown in light and dark
gray, respectively. Side chains of Asp107
and His275 are in ball and stick represen-
tation. The figure was drawn using BOB-
SCRIPT (15).
FIG. 5. Superimposition of the cores of epoxide hydrolase from
A. radiobacter AD1 (black), haloalkane dehalogenase from X.
autotrophicus (white), and bromoperoxidase A2 from S. aureo-
faciens (gray). A, superimposition of the central b-sheet. B, superim-
position of the region around the position of the nucleophile, with
b-strand 5, a-helix 3, and b-strand 6. The figure was produced using
MOLSCRIPT (39).
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the crystal structure, this water molecule is in contact with the
solvent via a narrow tunnel between the core and cap domains
(Fig. 4). This tunnel resembles the active site back entrance in
bromoperoxidase A2, which was proposed to provide access to
the active site for small molecules participating in the reaction,
like peroxide and halide, or to expel water molecules from the
active site during substrate binding (27). In epoxide hydrolase,
it seems more likely that the tunnel serves to replenish the
hydrolytic water molecule after the reaction has been
completed.
The third member of the catalytic triad, Asp246, assists
His275 in activating the hydrolytic water molecule (6). To our
surprise it is not at hydrogen bonding distance from the Nd1
atom of His275, but it has moved away into the solvent region.
This is most probably a consequence of crystal packing forces:
the Asp246 3 Ala mutation strongly decreases the activity of
the enzyme (;0.5% of the wild type activity) (6), and such a
dramatic effect on activity is difficult to rationalize for the
position of the residue as observed in our crystals. The exposed
position of Asp246 has made it possible for the Gln134 side chain
to move into the active site and block it (Fig. 3). Because a
Gln134 3 Ala mutant has an activity comparable with that of
wild-type enzyme, it is unlikely that Gln134 is normally present
in the active site. However, human microsomal epoxide hydro-
lase has been reported to be inhibited by amides (32). The A.
radiobacter epoxide hydrolase shows competitive inhibition by
amides as well, especially by compounds like phenylacetamide
(Ki 5 30 mM).
3 Therefore, we conclude that the Gln134 side chain
may act as such an inhibitor, mimicking the binding mode of
epoxide substrates. Thus, the combination of crystal contacts of
helix a10 (residues 252 to 261) and the affinity of the active site
for amide compounds have probably led to the observed ex-
posed position of Asp246. Nevertheless, the high structural sim-
ilarity (Fig. 5) between the core domains of epoxide hydrolase,
haloalkane dehalogenase, bromoperoxidase A2, and human
pancreatic lipase allowed us to use the latter three enzyme
structures as templates to remodel the loops containing Asp246
and Gln134. The result is a plausible model of the active site site
in the fully active enzyme (Fig. 7).
In the crystal structure the Gln134 side chain oxygen is
hydrogen-bonded to the hydroxyl group of Tyr152 and Tyr215
(Fig. 3). These two tyrosines are the only acidic functional
groups present in the active site that can facilitate the opening
3 R. Rink and D. B. Janssen, manuscript in preparation.
FIG. 6. Stereo view of the water-me-
diated interaction between Asp131
and His275 and of the oxyanion hole
in epoxide hydrolase. Hydrogen bonds
are shown as dashed lines. Side chains,
water molecules, and the HGWP motif
are in ball and stick representation. The
catalytic water molecule is labeled WAT.
The figure was produced using MOL-
SCRIPT (39).
FIG. 7. Stereo view of the active site
of the model of epoxide hydrolase.
Side chains and water molecules are in
ball and stick representation. The cata-
lytic water molecule is labeled WAT. The
figure was drawn using MOLSCRIPT
(39).
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of the epoxide ring by hydrogen bonding and protonating the
epoxide oxygen. In agreement with this hypothesis, mutagen-
esis studies of these tyrosines have shown that only a double
Tyr-Phe mutant is completely inactive, suggesting that both
Tyr152 and Tyr215 are able to provide the proton needed for the
opening of the epoxide ring.4 Because Tyr215 is absolutely con-
served within the epoxide hydrolase family and Tyr152 is
mostly conserved in the soluble epoxide hydrolases, it is likely
that the Tyr activation is a general property of this class of
enzymes (Fig. 8). In the past, one of three lysines, Lys173,
Lys174, and Lys177, was proposed to be involved in the proton-
ation (6), but the crystal structure of Ephy unambiguously
shows that these three lysine residues are located far from the
active site, exposed to the solvent on top of the cap domain.
Position and Function of Asp131—The Asp246 3 Ala muta-
tion resulted in a strong reduction of enzymatic activity. Nev-
ertheless, this mutant still has some residual activity (;0.5%
that of wild type activity), indicating the importance of Asp246
in catalysis but not its essentiality (6). The three-dimensional
structure of Ephy shows the presence of another aspartic acid,
Asp131, which may act as a backup of Asp246 (Fig. 3). Asp131 is
located between strand b6 and the first helix of the cap domain,
with its side chain in close contact with the imidazole ring of
the catalytic His275. A water molecule, present in all four mono-
mers in the asymmetric unit, bridges the interaction between
Od2 of Asp131 and Nd1 of His275 (Fig. 6).
Asp131 is at an equivalent position to Asn148 in haloalkane
dehalogenase. In the dehalogenase, Asn148 is involved in a
hydrogen-bonding stabilization of the active site (10, 26, 30).
Like Asn148, Asp131 in Ephy also shows slightly unusual back-
bone torsion angles. Furthermore, in the dehalogenase, the
activity of an Asp260 3 Asn mutant could be restored by an
Asn1483 Asp/Glu mutation. This shows that the catalytic triad
in DhlA can be either Asp-His-Asp260 or Asp-His-Asp148 (33).
The same could be true for Ephy, where Asp131 could take over
the function of Asp246 by a simple rotation around the x1 and
x2 torsion angles, which would allow its side chain to be hy-
drogen-bonded to His275 Nd1.
A similar shift of functional residues has been observed for
Pseudomonas glumae lipase (Pgl) (34) and Hpl (35), two other
members of the a/b hydrolase-fold family. In Pgl, Glu288 can
take over the role of Asp263 as the acid residue of the catalytic
triad. Glu288 Oe2 and Asp263 Od2 of Pgl match the positions of
Asp131 Od2 and of its hydrogen-bonded water molecule in Ephy.
In human pancreatic lipase, an alternative catalytic triad is
present in which the acid catalytic residue is shifted from
b-strand 7 to b-strand 6 at position 176. Asp176 of Hpl overlaps
with Asp131 in Ephy, with the Asp176 Od2 atom matching the
position of the water molecule hydrogen-bonded to Asp131 in
Ephy. These observations make Asp131 a very interesting res-
idue for site-specific mutational studies to further probe its role
in catalysis.
Oxyanion Hole—A conserved HGXP tetrapeptide motif (X 5
any amino acid) is found in epoxide hydrolases and other a/b
hydrolase-fold enzymes (2, 3). The HGWP motif of Ephy is
located in a sharp cis-proline turn (Trp38-Pro39), which is sta-
bilized by the hydrogen bond between His36 Nd1 and the back-
bone carbonyl oxygen of Gly37 (Fig. 6).
In haloalkane dehalogenase, this sequence motif is HGEP,
and the main chain N atom of the glutamate residue (Glu56) is,
together with the peptide nitrogen atom of residue Trp125, part
of the oxyanion hole, interacting with the Od2 atom the nucleo-
phile Asp124 (10, 26). In epoxide hydrolase, a similar hydrogen
bonding pattern is present between the Od2 atom of the nu-
cleophile Asp107 and the amide nitrogen atoms of Trp38 and
Phe108. Thus these peptide nitrogen atoms are in an optimal
position to stabilize the negative charge that develops on the
Od2 atom of the nucleophile during the hydrolysis of the ester
intermediate. In addition, the negative charge on Asp107 Od2
may be further stabilized by the a-helix dipole of helix a3 (36).
A second role of the tetrapeptide motif may be in stabilizing
the position of the putative hydrolytic water molecule (Fig. 6).
Indeed, in the crystal structure this water molecule is at inter-
acting distance to the backbone oxygen atom of Trp38.
These essential structural functions may explain the impor-
tance of the HGXP motif for enzymatic activity within the
epoxide hydrolase family, as already demonstrated by muta-
tion of His to Ala in the rat microsomal epoxide hydrolase (37).
Conclusions—The x-ray structure reveals for the first time
the fold of an epoxide hydrolase and provides novel, detailed
information on the residues involved in the enzymatic mecha-
nism. It localizes the catalytic residues, the hydrolytic water
molecule, and the position of the oxyanion hole, and it proposes
a possible backup for the acidic member of the catalytic triad.
Most importantly, it unambiguously identifies the previously
unanticipated Tyr152/Tyr215 as the acidic group responsible for
binding and possibly protonation of the transition state of the
formation of the ester intermediate. The residues important for
catalysis are conserved within the epoxide hydrolase family.
Therefore all these structural features are likely to be shared
by other epoxide hydrolases and allow us to gain a better
understanding of the behavior and mechanism of this class of
biologically and biotechnologically important enzymes. At pres-
ent we are investigating the structural basis of the enzymatic
enantioselectivity by mutation analysis and by docking the
substrates in the modeled active site.
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